CXCR4 Promotes Tumor Stemness Maintenance and CDK4/6 Inhibitors Resistance in ER-Positive Breast Cancer

Investigators focused on cancer stem cells, a critical contributor to cancer metastasis and therapy resistance, and detected an upregulation of stemness in our established palbociclib-resistant ER-positive breast cancer cells.